DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
-3.27%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$6.01B
AUM Growth
+$262M
(+4.6%)
Cap. Flow
-$204M
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159
Top Buys
| 1 |
WAY
Waystar Holding Corp
WAY
|
$106M |
| 2 |
Gilead Sciences
GILD
|
$102M |
| 3 |
CVS Health
CVS
|
$57.6M |
| 4 |
Baxter International
BAX
|
$52.6M |
| 5 |
Cullinan Oncology
CGEM
|
$37.4M |
Top Sells
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$136M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$80.7M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$63.2M |
| 4 |
Oscar Health
OSCR
|
$38.2M |
| 5 |
Viking Therapeutics
VKTX
|
$38M |
Sector Composition
| 1 | Healthcare | 83.29% |
| 2 | Industrials | 0.67% |
| 3 | Technology | 0.57% |
| 4 | Financials | 0.44% |
| 5 | Consumer Discretionary | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
B&G Foods
BGS
$374M
| – | – |
-30,521
| Closed | -$349K |
|
477
BJs Wholesale Club
BJ
$12.8B
| – | – |
-6,956
| Closed | -$526K |
|
478
Bristol-Myers Squibb
BMY
$96B
| – | – |
-5,370
| Closed | -$291K |
|
479
Berry Corp
BRY
$249M
| – | – |
-14,689
| Closed | -$118K |
|
480
Blackstone Secured Lending
BXSL
$6.72B
| – | – |
-13,272
| Closed | -$413K |
|
481
Cardinal Health
CAH
$35.7B
| – | – |
-2,276
| Closed | -$255K |
|
482
Pathward Financial
CASH
$1.74B
| – | – |
-6,188
| Closed | -$312K |
|
483
C4 Therapeutics
CCCC
$194M
| – | – |
-28,590
| Closed | -$234K |
|
484
Cerus
CERS
$255M
| – | – |
-59,637
| Closed | -$113K |
|
485
Confluent
CFLT
$6.67B
| – | – |
-8,962
| Closed | -$274K |
|
486
Americold
COLD
$3.98B
| – | – |
-13,995
| Closed | -$349K |
|
487
Columbia Sportswear
COLM
$3.09B
| – | – |
-4,216
| Closed | -$342K |
|
488
Campbell Soup
CPB
$10.1B
| – | – |
-5,701
| Closed | -$253K |
|
489
Carter's
CRI
$1.05B
| – | – |
-3,743
| Closed | -$317K |
|
490
Corteva
CTVA
$49.1B
| – | – |
-5,058
| Closed | -$292K |
|
491
Customers Bancorp
CUBI
$2.13B
| – | – |
-4,297
| Closed | -$228K |
|
492
DuPont de Nemours
DD
$32.6B
| – | – |
-5,021
| Closed | -$385K |
|
493
Quest Diagnostics
DGX
$20.5B
| – | – |
-2,157
| Closed | -$287K |
|
494
Deluxe
DLX
$876M
| – | – |
-17,885
| Closed | -$368K |
|
495
Ginkgo Bioworks
DNA
$660M
| – | – |
-874
| Closed | -$40.6K |
|
496
Leonardo DRS
DRS
$11B
| – | – |
-31,888
| Closed | -$704K |
|
497
Dyne Therapeutics
DYN
$2.02B
| – | – |
-7,940
| Closed | -$225K |
|
498
Electronic Arts
EA
$42.2B
| – | – |
-6,602
| Closed | -$876K |
|
499
Ecolab
ECL
$77.6B
| – | – |
-1,107
| Closed | -$256K |
|
500
Ecovyst
ECVT
$1.03B
| – | – |
-23,217
| Closed | -$259K |
|